News
VYNE pauses VYN202 psoriasis trial after FDA clinical hold tied to animal toxicity data; separate vitiligo trial remains on ...
Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback